Revolution Medicines, Inc. (RVMD) is a clinical-stage precision oncology company that develops novel targeted therapies for patients with RAS-addicted cancers, which represent approximately 30% of human cancers; its research and development…
HQ: Redwood City, CA, United States of Americawww.revmed.com
USD172.29-2.30%vs prev. close
Performance
1W
-10.40%
1M
-10.97%
3M
-15.42%
1Y
+167.61%
YTD
+116.31%
Valuation
P/E
—
EPS TTM
-8.92
Dividend yield
—
Size and risk
Market cap
$37.3B
Beta
1.43
Price history
RVMD price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
Revolution Medicines
RVMD
Biotechnology
Mkt cap (USD bn)
37.3
P/E
—
Div yld
—
1W
-10.4%
1M
-11.0%
3M
-15.4%
6M
+18.3%
1Y
+167.6%
YTD
+116.3%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Revolution Medicines
RVMD
Biotechnology
37.3
—
—
-10.4%
-11.0%
-15.4%
+18.3%
+167.6%
+116.3%
Subscribe to Equity Analytics to compare RVMD with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.